Clinical Trials on Carcinoma Colon in Russian Federation
Total 545 results
-
R-PharmCompletedAdvanced/Metastatic Non-Small Cell Lung CancerGermany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
-
AstraZenecaActive, not recruitingAdvanced Non Small Cell Lung CancerCanada, Poland, Taiwan, United States, Korea, Republic of, Japan, Russian Federation, Ukraine
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung CancerCanada, Netherlands, Spain, France, Japan, Russian Federation, Germany, Belgium, Greece, Turkey, Taiwan, United States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedNon Small Cell Lung CancerUnited States, Poland, Germany, Russian Federation, Latvia, Ukraine
-
BIND TherapeuticsCompletedSquamous Cell Non-small Cell Lung Cancer | KRAS Positive Patients With Non-small Cell Lung CancerUnited States, Russian Federation
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Merck Healthcare Germany GmbH, an affiliate of Merck KGaA, Darmstadt, GermanyActive, not recruitingCarcinoma, Renal CellGermany, Greece, Belgium, Russian Federation
-
PfizerCompletedSquamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Spain, Korea, Republic of, Czechia, Taiwan, Serbia, Japan, Slovakia, Mexico, Romania, Hungary, Italy, Poland, Russian Federation, Ukraine
-
PfizerTerminatedNon-Small Cell Lung Cancer | Urothelial CancerKorea, Republic of, United States, Taiwan, Poland, Spain, Russian Federation, Italy, Hungary
-
Sabine RhodeRuhr University of BochumUnknownGastric Cancer | Colorectal Cancer | Ovarian Cancer | Ascites | Pseudomyxoma Peritonei | Pancreas Cancer | Chemotherapeutic Toxicity | Pleural Effusion | Gallbladder Cancer | CUP | Appendix Cancer | Pleural Mesothelioma | Peritoneum Cancer | Peritoneum Neoplasm | Pleural CancerSingapore, France, Germany, Australia, Argentina, Austria, Belgium, Denmark, Italy, Poland, Russian Federation, Spain, Switzerland
-
Eisai Inc.Active, not recruitingCarcinoma, HepatocellularUnited States, Spain, United Kingdom, Australia, Sweden, Italy, Austria, Germany, Portugal, Russian Federation
-
GlaxoSmithKlineTerminatedLung Cancer, Non-Small CellUnited States, France, Germany, Russian Federation, Poland, Italy
-
SanofiCompletedNon-small Cell Lung CancerFrance, Romania, Poland, Croatia, Korea, Republic of, Italy, Chile, United States, Australia, Germany, Russian Federation, Serbia, Ukraine
-
AstraZenecaCompletedNon-Small Cell Lung CancerItaly, Spain, France, Korea, Republic of, Hungary, Japan, China, Taiwan, Hong Kong, Germany, Russian Federation
-
TularikTerminatedHepatocellular CarcinomaUnited States, Russian Federation, United Kingdom, Singapore, Thailand, Ukraine, Brazil, China, Poland, Puerto Rico, South Africa
-
pharmaand GmbHCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer | Other Solid Tumor | Metastatic Castration-Resistant Prostate CancerIsrael, Italy, Canada, Russian Federation, United Kingdom, Poland
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCPoland, Taiwan, Thailand, Vietnam, United States, Korea, Republic of, Hungary, Russian Federation, Turkey, China, Australia, Netherlands
-
AVEO Pharmaceuticals, Inc.CompletedAdvanced Renal Cell CarcinomaUnited States, Bulgaria, Canada, Chile, Czechia, France, Hungary, India, Italy, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedAdvanced or Metastatic Non-Small Cell Lung CancerUnited States, Australia, Brazil, Czech Republic, Russian Federation, Singapore
-
SanofiActive, not recruitingBreast Cancer Metastatic | Pancreatic Carcinoma MetastaticSpain, Korea, Republic of, Turkey, Chile, Netherlands, Russian Federation, Taiwan, United States, Argentina, Hungary
-
Oncolytics BiotechCompletedCarcinoma, Squamous Cell of the Head and NeckUnited States, Canada, Spain, Belgium, United Kingdom, Greece, Germany, Hungary, Poland, Slovenia, France, Italy, Russian Federation
-
BioNumerik Pharmaceuticals, Inc.Crown BioscienceCompletedOvarian CancerPoland, Russian Federation, Romania, Hungary, Lithuania
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellUnited States, Estonia, France, Korea, Republic of, United Kingdom, Germany, Japan, Russian Federation, Poland
-
BayerCompletedCarcinoma, HepatocellularJapan, China, Slovakia, Croatia, France, Hungary, Indonesia, Korea, Republic of, Malaysia, Singapore, Spain, Sweden, Thailand, Philippines, Colombia, Czech Republic, Hong Kong, Italy, Kazakhstan, Mexico, Romania, Russian Federation, Ukrain... and more
-
Astellas Pharma Global Development, Inc.CompletedCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction | CLDN18.2-positive Adenocarcinoma of Esophagus | CLDN18.2-positive Gastric AdenocarcinomaBulgaria, Czechia, Germany, Latvia, Russian Federation, Ukraine
-
Glycotope GmbHCompletedFallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Epithelial Cancer RecurrentGermany, Hungary, Italy, Poland, Romania, Russian Federation, Spain, United Kingdom
-
AbbVie (prior sponsor, Abbott)BiogenCompletedOvarian Cancer, Primary Peritoneal CancerUnited States, Australia, Belgium, Italy, Poland, Russian Federation, Spain, Sweden, Switzerland
-
Byondis B.V.CompletedEndometrial CancerKorea, Republic of, Singapore, Russian Federation, Ukraine, United States, Poland, Serbia
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedFGFR2 Gene Mutation | Advanced CholangiocarcinomaUnited States, Belgium, Germany, Italy, Korea, Republic of, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
GlaxoSmithKlineMerck Sharp & Dohme LLCTerminatedNeoplasms, Head and NeckUnited States, Argentina, Italy, Spain, Belgium, Denmark, Poland, Canada, Germany, Korea, Republic of, Ireland, Japan, United Kingdom, Romania, Hungary, Australia, France, Brazil, Sweden, Russian Federation
-
AstraZenecaParexelWithdrawnNon Small Cell Lung CancerItaly, Russian Federation, Spain, China, Netherlands, United States, Taiwan, France, Germany
-
Rainier TherapeuticsTerminatedUrinary Bladder Disease | Locally Advanced or Metastatic Urothelial Cell Carcinoma | Urological DiseasesUnited States, Spain, Belgium, France, Germany, Italy, Korea, Republic of, Turkey, Hungary, Netherlands, Serbia, Poland, Russian Federation, Sweden, Moldova, Republic of, Denmark, Ukraine
-
Genzyme, a Sanofi CompanyActive, not recruitingMedullary Thyroid Cancer | Locally Advanced or Metastatic Medullary Thyroid CancerAustralia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czechia, Denmark, Finland, Germany, Greece, India, Israel, Italy, Korea, Republic of, Poland, Russian Federation, Sweden, United Kingdom
-
CEL-SCI CorporationTeva Branded Pharmaceutical Products R&D, Inc.; Orient Europharma Co., Ltd.CompletedSquamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of the Soft PalateSpain, Taiwan, United States, United Kingdom, Romania, India, Croatia, Belarus, Hungary, Bosnia and Herzegovina, Russian Federation, Austria, Canada, France, Israel, Italy, Malaysia, Poland, Serbia, Sri Lanka, Thailand, Turkey, Ukraine
-
Bristol-Myers SquibbNektar TherapeuticsCompletedRenal Cell CarcinomaUnited States, Argentina, Brazil, Canada, France, Germany, Mexico, Russian Federation
-
Jounce Therapeutics, Inc.TerminatedNSCLCLatvia, Bosnia and Herzegovina, Russian Federation, Romania, Turkey, Belarus, Bulgaria, Croatia, Hungary, Serbia, Slovakia, Ukraine, Georgia, Moldova, Republic of
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CarcinomaFrance, United States, Korea, Republic of, Belgium, Taiwan, Turkey, Russian Federation, Spain, Italy, United Kingdom, Brazil, Belarus, Poland
-
Bristol-Myers SquibbCompletedLocally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal JunctionFrance, Poland, Russian Federation, Taiwan, United States, Hong Kong, Spain, Germany, Italy, Japan, Korea, Republic of, Singapore
-
SanofiCompletedOvarian Cancer RecurrentBelgium, Russian Federation, Poland, Spain, Czech Republic, United States, France, Germany, Italy, Ukraine
-
AVEO Pharmaceuticals, Inc.CompletedAdvanced Renal Cell CarcinomaUnited States, Argentina, Bulgaria, Canada, Chile, Czechia, France, Hungary, India, Italy, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom
-
AmgenTerminatedAdenocarcinoma of the Pancreas | Locally Advanced | UnresectableSpain, Belgium, Denmark, Poland, United States, Korea, Republic of, Russian Federation, Austria, Portugal, United Kingdom, Germany, Hungary, Czech Republic
-
Boehringer IngelheimActive, not recruitingNeoplasms | Non-squamous, Non-Small-Cell Lung CancerUnited States, Spain, Korea, Republic of, France, Hong Kong, United Kingdom, Germany, Australia, Taiwan, Poland, Russian Federation, Ukraine
-
Peregrine PharmaceuticalsCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, India, Georgia, Russian Federation, Ukraine
-
Eli Lilly and CompanyCompletedA Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung CancerNon-Small Cell Lung Cancer Stage IVUnited States, Italy, Spain, Australia, France, Germany, Hungary, Korea, Republic of, Poland, Romania, Russian Federation, Taiwan, Ukraine
-
Hoffmann-La RocheCompletedNon-Small-Cell Lung CarcinomaUnited States, Spain, France, Italy, Belgium, Korea, Republic of, Taiwan, United Kingdom, Luxembourg, Australia, Netherlands, Germany, Singapore, Denmark, Russian Federation, Sweden
-
Hoffmann-La RocheCompletedOvarian CancerFrance, Spain, Brazil, United Kingdom, Netherlands, Italy, Russian Federation, Sweden, Norway
-
Immatics Biotechnologies GmbHCompletedMetastatic Renal Cell CarcinomaUnited States, France, Romania, United Kingdom, Italy, Russian Federation, Poland, Germany, Hungary, Netherlands, Norway
-
PfizerCompletedNSCLC | SCCHN | Part 1 | MELANOMA | OVCA | SARCOMA | OTHER SOLID TUMORS | Part 1 and 2 | UROTHELIAL CARCINOMAUnited States, Korea, Republic of, Russian Federation, Poland, Malaysia, Bulgaria, Ukraine
-
Genta IncorporatedNational Cancer Institute (NCI)UnknownLung CancerUnited States, Canada, Russian Federation
-
Mateon TherapeuticsTerminatedAnaplastic Thyroid CancerUnited States, India, Belarus, Bulgaria, Egypt, Israel, Italy, Poland, Romania, Russian Federation, Ukraine, United Kingdom
-
AstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell LungPoland, Taiwan, India, Mexico, Russian Federation, Turkey, China, Korea, Republic of, Philippines, Hong Kong